Respiratory Syndrome
📧 Sign up to get email alerts when something new happens for Respiratory Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: COVID-19 Vaccine Response in Chronic Respiratory Conditions
A completed clinical trial evaluated the response to a COVID-19 vaccine in individuals with SARS-CoV infection.
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19 [Phase 2]
Phase 2 clinical trial evaluating inhaled nitric oxide for SARS and COVID-19 completed; results have been posted.
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Steroid Treatment for Severe Acute Respiratory Infection (STAR) Trial [Phase 4]
The STAR trial is a Phase 4 study evaluating steroid treatment for severe acute respiratory infection in patients with hypoxemia; recruitmen…
-
CLINICAL_TRIALS withdrawal · 2026-02-10Clinical Trial Update: Direct Topical Lung T3 Treatment to Improve Outcome & Sequelae of COVID-19 Acute Respiratory Distress Syndrome [Phase 2]
Phase 2 trial of inhaled triiodothyronine (T3) for COVID-19–associated ARDS has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-12-19Clinical Trial Update: Intermediate IND Severe Illness COVID-19 CP [Phase 1]
A Phase 1 trial evaluating convalescent plasma for severe COVID-19 has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: Antibody Detection of Vaccine-Induced Secretory Effects
A completed clinical trial investigating antibody detection of vaccine-induced secretory effects.
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: KIDney Injury in Times of COVID-19 (KIDCOV)
The KIDCOV trial at UCSF is currently recruiting to study kidney injury in the context of SARS-CoV infection and COVID-19.
-
CLINICAL_TRIALS trial_result · 2025-06-17Clinical Trial Update: COVID-19 Persistence in Stool
This completed clinical trial investigated how long SARS-CoV persists in stool samples in infected individuals. The record summarizes the st…
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: SARS-CoV-2 Human Challenge Characterisation Study [NA]
Imperial College London's SARS-CoV-2 human challenge characterization study has completed and posted its results. The study centers on chara…
-
CLINICAL_TRIALS trial_result · 2025-04-10Clinical Trial Update: Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine [Phase 1, Phase 2]
This clinical trial update reports safety and immunogenicity results from Phase 1/Phase 2 testing of an investigational influenza and COVID-…
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: COVID-19 Health Professional Impact Study [NA]
The COVID-19 Health Professional Impact Study (NCT04527432), sponsored by The Royal Wolverhampton Hospitals NHS Trust, has completed.
-
CLINICAL_TRIALS other · 2025-02-20Clinical Trial Update: Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19 [Phase 3]
Phase 3 clinical trial evaluating prevention of pulmonary complications in surgical patients at risk of COVID-19 has been suspended. Sponsor…
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: A Phase 1/2 Safety and Immunogenicity Trial of COVID-19 Vaccine COVIVAC (Phase 1) [Phase 1]
Clinical trial update reporting the completion of the Phase 1/2 safety and immunogenicity trial of the COVID-19 vaccine COVIVAC, with result…
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Camostat Mesilate Treating Patients With Hospitalized Patients With COVID-19 [Phase 2]
Phase 2 trial update reports that camostat mesilate in hospitalized COVID-19 patients has completed, with results posted. The document also …
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: Imaging Immune Activation in COVID-19 [Phase 2]
Phase 2 clinical trial evaluating imaging-based immune activation in COVID-19 is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: Respiratory Virus Hospitalization Study (FLU 003 Plus)
A clinical trial update for FLU 003 Plus on respiratory virus hospitalizations shows the study status as completed, and lists influenza, Mid…
-
CLINICAL_TRIALS trial_result · 2024-06-06Clinical Trial Update: Renal Biomarkers in AKI and COVID-19
Completed clinical trial evaluating renal biomarkers in patients with acute kidney injury and COVID-19.
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19)
A terminated clinical trial evaluating a predictive model for severity and disease progression in influenza-like illness, including COVID-19…
-
CLINICAL_TRIALS trial_result · 2024-05-01Clinical Trial Update: Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms [NA]
The clinical trial evaluating vagus nerve stimulation for COVID-19 respiratory symptoms was terminated, and results have been posted (May 1,…
-
CLINICAL_TRIALS trial_result · 2024-02-12Clinical Trial Update: Safety and Tolerability of COVID-19 Vaccine (ABNCoV2) [Phase 1]
Phase 1 results indicate safety and tolerability of the ABNCoV2 COVID-19 vaccine, with results posted on 2024-02-12. The study status is com…
-
CLINICAL_TRIALS trial_result · 2024-01-11Clinical Trial Update: Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial [Phase 3]
Phase 3 trial evaluating anti-coronavirus therapies to prevent progression of COVID-19 has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Extracellular Vesicles From Mesenchymal Cells in the Treatment of Acute Respiratory Failure [Phase 1, Phase 2]
A phase 1/2 clinical trial is investigating extracellular vesicles derived from mesenchymal cells for treating acute respiratory failure, in…
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19 [Phase 3]
A Phase 3 clinical trial comparing best supportive care with or without low-dose whole lung radiation therapy for COVID-19-related pneumonia…
-
CLINICAL_TRIALS trial_result · 2023-07-13Clinical Trial Update: COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19) [Phase 3]
Phase 3 trial COVID-OUT evaluated early outpatient treatment of SARS-CoV-2 infection with nitazoxanide, ivermectin, and fluvoxamine; results…
-
CLINICAL_TRIALS trial_result · 2023-01-30Clinical Trial Update: A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19 [Phase 1]
Phase 1 trial assessing safety, reactogenicity, and immunogenicity of CVnCoV in healthy adults for COVID-19 completed with results posted in…